More than a million people with heart disease could be prescribed weight loss jabs on the NHS to prevent them from having heart attacks or strokes.
Sold under the brand name Wegovy and made by Novo Nordisk, the weekly jab is a type of drug called a GLP-1 receptor agonist. It works by mimicking the natural hormone which regulates blood sugar, appetite and digestion.
